These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9185031

  • 1. Lack of effect of a diuretic added to diltiazem.
    MacGregor GA, Cappuccio FP.
    J Hum Hypertens; 1997 Apr; 11(4):249-50. PubMed ID: 9185031
    [No Abstract] [Full Text] [Related]

  • 2. [High dose sartan plus diuretic. More power in hypertension and its sequelae].
    MMW Fortschr Med; 2003 Mar 13; 145(11):59. PubMed ID: 12688201
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.
    Plouin PF.
    J Hum Hypertens; 1997 Sep 13; 11 Suppl 2():S65-6. PubMed ID: 9331012
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension.
    Philipp T, Letzel H, Arens HJ.
    J Hum Hypertens; 1997 Sep 13; 11 Suppl 2():S67-8. PubMed ID: 9331013
    [No Abstract] [Full Text] [Related]

  • 7. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr 01; 146(14):45. PubMed ID: 15344757
    [No Abstract] [Full Text] [Related]

  • 8. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK, Fischer HM, Bohlscheid V, Pittrow D.
    MMW Fortschr Med; 2003 Apr 03; 145(14):42. PubMed ID: 15072279
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
    Dezii CM.
    Manag Care; 2001 Feb 03; 10(2 Suppl):6-10. PubMed ID: 11729406
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
    Dezii CM.
    Manag Care; 2000 Sep 03; 9(9 Suppl):2-6. PubMed ID: 11729417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Fast to the blood pressure goal. Lengthy dose adjustments harm compliance].
    MMW Fortschr Med; 2003 Sep 25; 145(39):53. PubMed ID: 14649079
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct 13; 93(42):1748. PubMed ID: 15529964
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
    Punzi HA, Punzi CF.
    J Hum Hypertens; 2004 Sep 13; 18(9):655-61. PubMed ID: 15042114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.